Research Topics
Genomes and Genes | Charles B Nemeroff CBSummaryAffiliation: Emory University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Fostering foster care outcomes: quality of intervention matters in overcoming early adversityCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Cir, Ste 4000, Atlanta, GA 30322, USA
Arch Gen Psychiatry 65:623-4. 2008
Understanding the pathophysiology of postpartum depression: implications for the development of novel treatmentsCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuron 59:185-6. 2008....
The role of GABA in the pathophysiology and treatment of anxiety disordersCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322 4990, USA
Psychopharmacol Bull 37:133-46. 2003..This article reviews the findings implicating the GABA system in the pathophysiology of anxiety disorders and describes the potential role of agents that modulate GABA neurotransmission in the treatment of these disorders...
Neurotensin and dopamine interactionsE B Binder
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA
Pharmacol Rev 53:453-86. 2001..Last, because of the extensive literature on NT/DA interactions available in the rat, our discussion will be based primarily on studies using this species...
Neurobiological consequences of childhood traumaCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322 4990, USA
J Clin Psychiatry 65:18-28. 2004..The preclinical and clinical studies evaluating the consequences of early-life stress are reviewed...
Improving antidepressant adherenceCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 64:25-30. 2003....
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood traumaCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322
Proc Natl Acad Sci U S A 100:14293-6. 2003..Our results suggest that psychotherapy may be an essential element in the treatment of patients with chronic forms of major depression and a history of childhood trauma...
Prevalence and management of treatment-resistant depressionCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
J Clin Psychiatry 68:17-25. 2007..Given the public health importance of TRD, the relative absence of adequately powered, double-blind trials is striking...
Advancing the treatment of mood and anxiety disorders: the first 10 years' experience with paroxetineCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Psychopharmacol Bull 37:6-7. 2003..Subsequent clinical trials led to the widespread, but short-lived, use of iproniazid for treatment of depression in 1957 and demonstration of its monoamine oxidase inhibitor properties...
Treatment of mood disordersCharles B Nemeroff
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, Georgia 30322, USA
Nat Neurosci 5:1068-70. 2002..The mechanisms of action of available medications are directing the field toward new research avenues. This review highlights those areas we believe will influence the field and soon lead to better treatment...
Stress, menopause and vulnerability for psychiatric illnessCharles B Nemeroff
Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA 30322, USA
Expert Rev Neurother 7:S11-3. 2007
Recent advances in the neurobiology of depressionCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Psychopharmacol Bull 36:6-23. 2002..Further clarification of the precise neurobiological changes occurring in depression has implications for the use and development of novel effective treatments for this disorder...
Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosingCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322 4990, USA
J Clin Psychiatry 63:5-11. 2002..Finally, imaging studies with positron emission tomography confirm significant differences between quetiapine and typical antipsychotics that may be indicative of their differences in mechanism of action and propensity for producing EPS...
Safety of available agents used to treat bipolar disorder: focus on weight gainCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 64:532-9. 2003..The potential for excessive weight gain as a side effect of certain psychopharmacologic agents remains a concern to both clinicians and patients...
Anxiolytics: past, present, and future agentsCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 64:3-6. 2003..The long-sought-after class of anxiolytics that are both effective and safe may be found in the new research being conducted with agents that selectively target GABA receptors and their subtypes...
Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axisCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
CNS Spectr 9:23-31. 2004..Each SSRI apparently has its own unique pharmacologic properties that likely underlie their observed differences in clinical use...
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIsCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 63:424-34. 2008..To compare venlafaxine and selective serotonin reuptake inhibitors (SSRIs; fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram) in the treatment of depression...
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanismsCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 31:1345-55. 2006..Mechanisms that mediate the beneficial effects of VNS therapy for treatment-resistant depression remain obscure. Suggestions for future research directions are described...
Novel treatments of schizophrenia: targeting the neurotensin systemB Kinkead
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
CNS Neurol Disord Drug Targets 5:205-18. 2006..The compilation of data suggests that NT receptor agonists may represent a novel class of antipsychotic drugs for the treatment of schizophrenia...
Are platelets the link between depression and ischemic heart disease?C B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
Am Heart J 140:57-62. 2000..The findings of clinical trials evaluating platelet responses to antidepressant treatment are described, and recommendations for future studies are proposed...
From clinical research to clinical practice: a 4-year review of ziprasidoneCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA
CNS Spectr 10:1-20. 2005..This monograph summarizes the efficacy, tolerability, and safety of oral ziprasidone in the treatment of schizophrenia, schizoaffective disorder, and bipolar mania...
Use of atypical antipsychotics in refractory depression and anxietyCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 66:13-21. 2005..Further double-blind, placebo-controlled studies of augmentation of antidepressants with atypical antipsychotics in refractory depression and anxiety are justified based on the available literature...
An ever-increasing pharmacopoeia for the management of patients with bipolar disorderC B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 61:19-25. 2000..Other recent approaches have included several anticonvulsant agents, as well as conventional and atypical antipsychotic agents...
Posttraumatic stress disorder: a state-of-the-science reviewCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322 4990, USA
J Psychiatr Res 40:1-21. 2006....
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatientsCharles B Nemeroff
Department of Psychiatry and Behavioral Science, Emory University School of Medicine, 101 Woodruff Circle, Room 4115, Atlanta, GA 30322 4990, USA
J Psychiatr Res 41:351-9. 2007..The efficacy profile of fluoxetine was somewhat less consistent. It is strongly recommended that future studies of comparative antidepressant efficacy be adequately powered to detect modest between-drug differences in efficacy...
The burden of severe depression: a review of diagnostic challenges and treatment alternativesCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA
J Psychiatr Res 41:189-206. 2007..Improved knowledge and treatment approaches for severe depression are necessary to facilitate remission, the ideal treatment goal...
The neurobiology of depression: inroads to treatment and new drug discoveryCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 66:5-13. 2005..In addition, studies of the CRF system have suggested molecular targets for new drug development, biological risk factors, and predictors of treatment response...
Drug development for anxiety disorders: new roles for atypical antipsychoticsWilliam H Carson
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, 30322, USA
Psychopharmacol Bull 38:38-45. 2004..Psychopharmacology Bulletin. 2004;38(Suppl 1): 38-45...
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety DisordersCharles B Nemeroff CB
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, 30322
Psychopharmacol Bull 38:14-20. 2004..Psychopharmacology Bulletin. 2004;38(Suppl 1): 14-20...
The depressed suicidal patient. Assessment and treatmentC B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Ann N Y Acad Sci 932:1-23. 2001..Clinicians encountering patients with depressive disorders should be proficient in the assessment and treatment of depression with suicidality...
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinityS Neil Vaishnavi
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322, USA
Biol Psychiatry 55:320-2. 2004..CONCLUSIONS: Milnacipran's binding and uptake inhibition profile more closely resembles that of the tricyclic antidepressants than that of duloxetine. Whether these differences observed in vitro manifest themselves in vivo is not clear...
Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separationCharlotte O Ladd
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA
Biol Psychiatry 55:367-75. 2004....
Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporterJonathan McConathy
Department of Psychiatry, Emory University, Atlanta, GA 30322, USA
Nucl Med Biol 31:705-18. 2004..Although both compounds displayed high affinity and selectivity for the human NET in vitro, these compounds did not enter the CNS in adequate amounts to be used in PET imaging studies...
Inhibition of norepinephrine uptake in patients with major depression treated with paroxetineMichelle L Gilmor
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, WMB Building, Atlanta, GA 30322, USA
Am J Psychiatry 159:1702-10. 2002....
Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separationLotta Arborelius
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Psychopharmacology (Berl) 176:248-55. 2004..Prolonged, daily maternal separation of rat pups induces several behavioral, endocrine and neurochemical changes similar to those observed in human depression...
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawalKelly H Skelton
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Psychopharmacology (Berl) 192:385-96. 2007....
Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female ratsBecky Kinkead
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Suite 4000 WMRB, 101 Woodruff Circle, Atlanta, GA 30322, USA
Psychoneuroendocrinology 33:178-87. 2008..These data support an effect of time of day and estrous cycle stage on PPI in female rats. The estrous cycle variations in PPI are mediated in part by endogenous NT...
The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systemsMichelle L Gilmor
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Dr, WMB Suite 4000, Atlanta, GA 30322, USA
J Pharmacol Exp Ther 305:434-9. 2003..The distinct actions of each drug on CRF systems may underlie their synergistic clinical effects...
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphismsKeizo Yoshida
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, USA
Am J Psychiatry 161:1575-80. 2004....
Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agentsJonathan McConathy
Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322, USA
Nucl Med Biol 32:593-605. 2005..Despite high in vitro affinity for the human NET, the uptake of [(11)C]3-BrPA in the brain and the heart was not displaceable with pharmacological doses of NET antagonists...
Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatmentSteven C Stout
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
J Pharmacol Exp Ther 300:1085-92. 2002..Additional studies are required to elucidate the functional consequences and mechanisms of this interaction...
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adultsElisabeth B Binder
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30329, USA
JAMA 299:1291-305. 2008..Both genetic and environmental factors are contributory, with child abuse providing significant risk liability...
Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transportersNachwa Jarkas
Center for Positron Emission Tomography, Emory University, Atlanta, GA 30322, USA
Nucl Med Biol 32:211-24. 2005..Arterial plasma metabolites of HOMADAM were analyzed in a rhesus monkey by HPLC and displayed a single peak that corresponded to unmetabolized HOMADAM. CONCLUSION: HOMADAM is an excellent candidate for PET primate imaging of brain SERTs...
Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch studyXiaohong Wang
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, GA 30322, United States
J Psychiatr Res 40:669-76. 2006..The results indicate that both atypical antipsychotic medications provided significant additional improvement in symptom severity in patients with schizophrenia previously on conventional antipsychotic agents...
The role of dopamine in the pathophysiology of depressionBoadie W Dunlop
Department of Psychiatry and Behavioral Sciences, Emory University, 101 Woodruff Circle, Atlanta, GA 30322, USA
Arch Gen Psychiatry 64:327-37. 2007
The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawalKelly H Skelton
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Eur J Pharmacol 571:17-24. 2007....
Persistent central nervous system effects of an adverse early environment: clinical and preclinical studiesDavid A Gutman
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000 WMRB, Atlanta, GA 30322, USA
Physiol Behav 79:471-8. 2003..The discussion will be framed in regards to a stress-diathesis model in which early adverse events result in a sensitized stress axis that predisposes individuals to develop mood disorders...
Partial response and nonresponse to antidepressant therapy: current approaches and treatment optionsRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77555 0188, USA
J Clin Psychiatry 63:826-37. 2002..Switching to an agent of a different class is probably optimal for those patients who fail to respond to first-line therapy...
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depressionJennifer C Felger
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Winship Cancer Institute, 1365 C Clifton Road, Atlanta, GA 30322, USA
Biol Psychiatry 62:1324-33. 2007..To establish a nonhuman primate model of cytokine-induced depression, we examined the effects of IFN-alpha on rhesus monkeys...
The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysisChristine Heim
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA
Depress Anxiety 15:117-25. 2002..Our findings suggest that a history of childhood abuse per se is related to increased neuroendocrine stress reactivity, which is further enhanced when additional trauma is experienced in adulthood...
Effects of sodium valproate on corticotropin-releasing factor systems in rat brainS C Stout
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 24:624-31. 2001..These results suggest that the mood stabilizing effects of valproic acid may be mediated in part by alterations in CRF neuronal activity...
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapineBecky Kinkead
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Pharmacol Exp Ther 315:256-64. 2005..These results provide evidence that the effects of antipsychotic drugs (APDs) may be differentially affected by the state of NT neurotransmission and, moreover, that APDs differ in their dependence on an intact NT system...
Hypercortisolemia and depressionCharles F Gillespie
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Suite 4000 WMRB, Atlanta, GA 30322, USA
Psychosom Med 67:S26-8. 2005..The authors review the history of techniques used to assess the functions of the HPA axis, evidence for hypercortisolemia as a state rather than trait component of depression, and treatment implications...
Persistent auditory hallucinations that are unresponsive to antipsychotic drugsStephen E Nicolson
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA
Am J Psychiatry 163:1153-9. 2006
A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depressionDominique L Musselman
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 67:288-96. 2006..Randomized, placebo-controlled trials of adequate power seeking to determine efficacy of antidepressants in the United States for the treatment of women with breast cancer and comorbid depression remain of paramount importance...
Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expressionKelly H Skelton
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
J Neurosci 24:9303-12. 2004..The marked increase in CRFergic neurotransmission is hypothesized to play a major role in benzodiazepine withdrawal...
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depressionC B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Dr, Suite 4000, Atlanta, GA 30322, USA
Am J Psychiatry 158:906-12. 2001..However, antidepressant therapy may be beneficial for patients who cannot tolerate high serum lithium levels or who have symptoms that are refractory to the antidepressant effects of lithium...
An evaluation of risperidone drug interactionsC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425 0742, USA
J Clin Psychopharmacol 21:408-16. 2001..Adherence to a few guidelines for the design of dosage regimens should limit the effect of drug-drug interactions on patient status and contribute to optimal pharmacotherapy with risperidone...
Importance of studying the contributions of early adverse experience to neurobiological findings in depressionChristine Heim
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 29:641-8. 2004....
Epidemiology of comorbid coronary artery disease and depressionBruce Rudisch
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 54:227-40. 2003....
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatmentLucile Capuron
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 54:906-14. 2003....
Involvement of neuropeptide systems in schizophrenia: human studiesRicardo Caceda
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine Atlanta, Georgia 30322, USA
Int Rev Neurobiol 78:327-76. 2007..Clearly, additional investigation into the role of neuropeptide systems in the etiology, pathophysiology, and treatment of schizophrenia is warranted...
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and predictionCharles L Raison
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
J Clin Psychiatry 66:41-8. 2005..All of these factors can be evaluated and addressed to limit neuropsychiatric morbidity during HCV treatment...
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuseD Jeffrey Newport
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 55:10-20. 2004....
Serotonin transporter: a potential substrate in the biology of suicideDavid C Purselle
Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 28:613-9. 2003..This paper provides a review of several studies that have evaluated the role of the SERT in the pathophysiology of suicide...
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas 77555 0188, USA
Biol Psychiatry 51:123-33. 2002..This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients...
The simultaneous determination of neurotensin and its major fragments by on-line trace enrichment HPLC with electrochemical detectionC D Kilts
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Life Sci 59:911-20. 1996..The improvements in assay specificity, signal-to-noise ratios, biomatrix compatibility and assayable sample volume compared to non-enrichment HPLC-EC are discussed...
Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitryK V Thrivikraman
Stress Neurobiology Laboratory, Department of Psychiatry and Behavioral Sciences, WMB 4000, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA
Brain Res 870:87-101. 2000....
Lower CSF oxytocin concentrations in women with a history of childhood abuseC Heim
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, WMRB, Atlanta, GA 30322, USA
Mol Psychiatry 14:954-8. 2009..If replicated, the association of lower adult CSF OT levels with childhood trauma might indicate that alterations in central OT function may be involved in the adverse outcomes of childhood adversity...
The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brainB Kinkead
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Brain Res Dev Brain Res 124:1-10. 2000..These results demonstrate that there is a critical time point in development before which the NT system does not respond to antipsychotic drug administration in the same manner as the mature rat...
Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptorL Martarello
Department of Radiology, Emory Center for Positron Emission Tomography, Emory University School of Medicine, 1634 Clifton Road N E, Atlanta, Georgia 30322, USA
Nucl Med Biol 28:187-95. 2001..However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB)...
Neurokinin(1) receptor antagonists as potential antidepressantsS C Stout
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Annu Rev Pharmacol Toxicol 41:877-906. 2001..The ongoing clinical trials with NK(1) receptor antagonists have served as an impetus for much needed, basic research in this field...
Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axesE Keen-Rhinehart
Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA
Mol Psychiatry 14:37-50. 2009..Molecular Psychiatry (2009) 14, 37-50; doi:10.1038/mp.2008.91; published online 12 August 2008...
The CRF system, stress, depression and anxiety-insights from human genetic studiesE B Binder
Max Planck Institute of Psychiatry, Munich, Germany
Mol Psychiatry 15:574-88. 2010..In-depth characterization of these variants will likely be important in furthering our understanding of the long-term consequences of adverse experience...
Emerging targets for antidepressant therapiesJeffrey J Rakofsky
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 2004 Ridgewood Dr, Suite 218, Atlanta, GA 30322, United States
Curr Opin Chem Biol 13:291-302. 2009..Focal brain stimulation therapies include vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS)...
Neuropharmacology of paroxetineCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Psychopharmacol Bull 37:8-18. 2003..The application of these findings of in vivo NET inhibition by paroxetine in the treatment of mood and anxiety disorders will be informed by further clinical studies...
New directions in the development of antidepressants: the interface of neurobiology and psychiatryCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322 4990, USA
Hum Psychopharmacol 17:S13-6. 2002..These are just two of the many new directions that will likely lead to the development of antidepressants in the near future...
Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot studyJ Douglas Bremner
Department of Psychiatry, Radiology and Emory Center for Positron Emission Tomography, Emory University School of Medicine, Atlanta, GA, USA
J Psychopharmacol 19:159-65. 2005..However, treatment associated improvements in memory and cognition did not achieve statistical significance. These findings suggest that phenytoin treatment may be associated with changes in brain structure in patients with PTSD...
Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugsElisabeth B Binder
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 29:2200-7. 2004..The effects of the NT receptor antagonist were paralleled by its effects on catalepsy in olanzapine--but not haloperidol--treated animals...
The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinologyElizabeth I Martin
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA
Clin Lab Med 30:865-91. 2010..The goal of this article is to describe the key biological similarities and differences between anxiety disorders...
Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxietyK M Penza
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Arch Womens Ment Health 6:15-22. 2003..These physiological maladaptations likely represent long-term risk factors for the development of psychopathology after exposure to additional stress...
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studiesC Heim
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 49:1023-39. 2001..The identification of the neurobiological substrates of early adverse experience is of paramount importance for the development of novel treatments for children, adolescents, and adults...
Clinical pharmacokinetics of quetiapine: an atypical antipsychoticC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
Clin Pharmacokinet 40:509-22. 2001..Subsequent clinical studies of the plasma concentration versus effect relationships for quetiapine may help to further define guidelines for dosage regimen design...
The evaluation and treatment of depression in primary careM T Compton
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA
Clin Cornerstone 3:10-22. 2001..Appropriate treatment of depression can result in improvement in emotional, cognitive, and behavioral symptoms of depression and reduce psychosocial impairment, disability, and associated medical morbidity...
Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuseC Heim
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Dr, Atlanta, GA 30322, USA
Am J Psychiatry 158:575-81. 2001..On subsequent stress exposure, women with a history of childhood abuse may hypersecrete CRF, resulting in down-regulation of adenohypophyseal CRF receptors and symptoms of depression and anxiety...
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporterM J Owens
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322
Clin Chem 40:288-95. 1994..In a pilot study, this deficit predicted treatment response to an experimental antidepressant. These findings support the hypothesis that alterations in 5-HT neurons play a role in the pathophysiology of depression...
The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysisJ M Radke
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, P.O. Box AF, 1639 Pierce Drive, 30322-4990, Atlanta, GA, USA
Eur J Pharmacol 411:129-134. 2001..These findings indicate that activation of glutamate receptors may indirectly stimulate neurotensin release...
Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findingsD L Musselman
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Dr, Atlanta, GA 30322, USA
Am J Psychiatry 158:1252-7. 2001..CONCLUSIONS: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression...
Paroxetine for the prevention of depression induced by high-dose interferon alfaD L Musselman
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
N Engl J Med 344:961-6. 2001..85). The incidence of adverse events was similar in the two groups. CONCLUSIONS: In patients with malignant melanoma, pretreatment with paroxetine appears to be an effective strategy for minimizing depression induced by interferon alfa...
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disordersEmad H Hamid
Clinical Brain Disorders Branch-IRP, National Institute of Mental Health, National Institutes of Health, 9000 Rockville Pike, Building 10 Room 4S237A, MSC 1379, Bethesda, MD 20892, USA
Biol Psychiatry 51:795-800. 2002....
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor geneRebekah G Bradley
Atlanta VA Medical Center, Georgia, USA
Arch Gen Psychiatry 65:190-200. 2008..Child abuse and trauma alter the endogenous stress response, principally corticotropin-releasing hormone and its downstream effectors, suggesting that a gene x environment interaction at this locus may be important in depression...
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuationMark Hyman Rapaport
Department of Psychiatry, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Neuropsychopharmacology 31:2505-13. 2006..1 and 64.1%, respectively (p < or = 0.05). Open-label risperidone augmentation substantially enhanced response in treatment-resistant patients, but the longer-term benefits of augmentation were not demonstrated in this study...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller
Brown University, Providence, Rhode Island 02906, USA
Biol Psychiatry 62:1371-9. 2007..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
J Clin Psychiatry 68:1014-23. 2007..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
Maintenance efficacy of divalproex in the prevention of bipolar depressionLaszlo Gyulai
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
Neuropsychopharmacology 28:1374-82. 2003....
Are mood disorders and obesity related? A review for the mental health professionalSusan L McElroy
Psychopharmacology Research and Eating Disorders and Obesity Research and Treatment Programs, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 65:634-51, quiz 730. 2004..We reviewed evidence regarding a possible relationship between mood disorders and obesity to better inform mental health professionals about their overlap...
Long-term behavioural and molecular alterations associated with maternal separation in ratsMelanie Lippmann
Department of Psychiatry, The University of Texas South Western Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9070, USA
Eur J Neurosci 25:3091-8. 2007..Recognition of these adaptations begins to define the brain regions, and neural circuitry, associated with persistent alterations induced by early life stressors and the development of mood disorders...
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
Neuropsychopharmacology 30:405-16. 2005..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorderJeffrey S Simon
Northbrooke Research Center, Brown Deer, WI 53223, USA
J Clin Psychiatry 66:1216-20. 2005..To determine the efficacy and tolerability of aripiprazole, a dopamine D2 and 5-HT1A receptor partial agonist, as augmentation of antidepressant treatment of partially responding and nonresponding patients with major depressive disorder...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 68:1246-56. 2007..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
Research Grants
- Emory-GSK-NIMH Collaborative Mood Disorders InitiativeClinton Kilts; Fiscal Year: 2007..abstract_text> ..
- Special Scientific Procedures: Statistical Modeling CoreCharles Nemeroff; Fiscal Year: 2007..abstract_text> ..
